BIANCHI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.523
EU - Europa 4.016
AS - Asia 3.894
SA - Sud America 480
AF - Africa 108
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 17.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.363
GB - Regno Unito 1.272
SG - Singapore 1.107
IT - Italia 1.005
CN - Cina 913
HK - Hong Kong 555
VN - Vietnam 445
SE - Svezia 429
BR - Brasile 345
DE - Germania 273
FR - Francia 222
RU - Federazione Russa 189
FI - Finlandia 142
KR - Corea 140
TR - Turchia 134
UA - Ucraina 134
BD - Bangladesh 119
CA - Canada 105
IN - India 92
ID - Indonesia 81
NL - Olanda 54
BG - Bulgaria 47
JP - Giappone 44
AR - Argentina 42
IR - Iran 41
IQ - Iraq 37
MX - Messico 34
PL - Polonia 32
ZA - Sudafrica 32
SI - Slovenia 30
LT - Lituania 25
AU - Australia 23
BE - Belgio 23
CO - Colombia 22
ES - Italia 21
PK - Pakistan 21
EC - Ecuador 20
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 18
CZ - Repubblica Ceca 18
KE - Kenya 17
QA - Qatar 17
EG - Egitto 16
IE - Irlanda 16
UZ - Uzbekistan 15
CL - Cile 14
MY - Malesia 13
CH - Svizzera 12
MA - Marocco 11
AT - Austria 10
DZ - Algeria 9
EU - Europa 9
JO - Giordania 9
PY - Paraguay 9
TW - Taiwan 9
BO - Bolivia 8
GR - Grecia 8
PH - Filippine 8
VE - Venezuela 8
LU - Lussemburgo 7
PT - Portogallo 7
TH - Thailandia 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
DK - Danimarca 5
IL - Israele 5
JM - Giamaica 5
MN - Mongolia 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
LB - Libano 4
NO - Norvegia 4
PS - Palestinian Territory 4
SN - Senegal 4
HR - Croazia 3
KZ - Kazakistan 3
RS - Serbia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
KG - Kirghizistan 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 17.033
Salva come PNG Salva come JPEG
Città #
Ashburn 953
Southend 949
Fairfield 818
Singapore 686
Santa Clara 661
Hong Kong 535
Chandler 464
Woodbridge 428
San Jose 409
Houston 403
Seattle 305
Cambridge 280
Wilmington 258
Ann Arbor 250
Nyköping 215
Modena 208
Beijing 203
Dearborn 199
Jacksonville 190
Council Bluffs 187
Hefei 187
London 166
Los Angeles 147
Ho Chi Minh City 132
New York 129
Chicago 124
Seoul 119
Hanoi 102
The Dalles 93
Helsinki 78
San Diego 78
Milan 75
Izmir 71
Jakarta 63
Salt Lake City 53
Shanghai 51
Lauterbourg 49
Munich 49
Princeton 49
Fremont 48
Sofia 47
Bologna 45
Buffalo 44
Eugene 44
Dallas 43
Shenzhen 38
São Paulo 38
Reggio Emilia 37
Moscow 36
Rome 36
Sant'Ilario d'Enza 36
Montreal 33
Tampa 33
Tokyo 32
Elk Grove Village 29
Orem 29
Toronto 29
Frankfurt am Main 28
Turku 26
Dong Ket 25
Phoenix 24
Des Moines 23
Bremen 22
Hillsboro 22
Boardman 21
Da Nang 20
Redwood City 20
Brussels 19
Parma 19
Warsaw 19
Columbus 18
Haiphong 18
Nuremberg 17
Atlanta 16
Chennai 16
Doha 16
Florence 16
Johannesburg 16
Nairobi 16
Poplar 16
Dublin 15
Falls Church 15
Amsterdam 14
Manchester 14
Naples 14
Denver 13
Guangzhou 13
Tashkent 13
Belo Horizonte 12
Sterling 12
Turin 12
Biên Hòa 11
Miami 11
Brasília 10
Brno 10
Brooklyn 10
Jinan 10
Lancaster 10
Palermo 10
Paris 10
Totale 11.785
Salva come PNG Salva come JPEG
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 565
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 510
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 471
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 445
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 429
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 427
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 412
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 403
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 385
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 384
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 372
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 371
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 368
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 367
Genomic landscape of megakaryopoiesis and platelet function defects 361
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 358
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 350
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 349
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 347
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 340
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 332
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 325
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 323
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 319
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 319
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 316
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 301
HGM 2010 Programme / Abstract 297
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 290
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 286
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 276
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 273
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 269
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 267
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 266
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 266
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 261
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 260
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 258
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 255
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 251
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 249
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 249
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 246
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 239
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 239
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 238
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 228
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 210
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 208
Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up 202
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 199
MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF 191
Silencing CD34 antigen in human hematopoietic stem cells 180
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 169
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis 97
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model 21
Totale 17.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/20221.191 57 97 143 72 58 77 51 78 119 95 189 155
2022/20231.520 172 192 135 131 190 167 29 135 159 34 74 102
2023/20241.078 49 47 83 112 146 77 200 126 10 31 60 137
2024/20252.899 83 28 50 164 574 451 262 210 264 123 354 336
2025/20265.403 374 182 352 614 984 353 702 230 551 579 363 119
Totale 17.189